CVE-2021-38289 is a privilege escalation vulnerability affecting Novastar-VNNOX-iCare Novaicare version 7.16.0. This flaw allows authenticated attackers to gain elevated privileges, potentially leading to unauthorized access to corporate information, SMTP server details, user deletion, and role viewing. With a CVSS score of 8.8 (HIGH), it presents a significant risk due to its low attack complexity and severe impact on confidentiality, integrity, and availability. Currently, there is no evidence of active exploitation, public exploit code (Metasploit, Nuclei, ExploitDB), or significant community discussion surrounding this vulnerability.
| Vendor | Product | Version(s) | CPE |
|---|---|---|---|
7.16.0CPE matchmatch criteria | cpe:2.3:a:novastar:novaicare:7.16.0:*:*:*:*:*:*:* |
CVSS version used by this source: 3.1
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
The average CVE in this peer group has 0.0 Twitter, 0.0 Reddit, 0.3 Bluesky, 0.1 Mastodon, and 0.2 GitHub mentions.
No media coverage found for this CVE.
The average CVE in this peer group has 0.1 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.
Remediation records are not available for this CVE.